Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 USD | +5.83% |
|
-1.26% | -74.21% |
Business Summary
Number of employees: 8
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gerry Proehl
CEO | Chief Executive Officer | 65 | 14-12-07 |
David Hale
FOU | Founder | 75 | 14-12-07 |
Kyri van Hoose
DFI | Director of Finance/CFO | 46 | 21-08-31 |
Sean Proehl
IRC | Investor Relations Contact | - | 21-08-31 |
Corporate Officer/Principal | 59 | 15-05-31 | |
General Counsel | 73 | 15-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Hale
FOU | Founder | 75 | 14-12-07 |
Gerry Proehl
CEO | Chief Executive Officer | 65 | 14-12-07 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 16-09-19 |
Mary Fisher
BRD | Director/Board Member | 62 | 21-07-31 |
Steven Mento
BRD | Director/Board Member | 72 | 21-07-31 |
Kathleen Scott
BRD | Director/Board Member | 55 | 21-07-31 |
Andrew Sandler
BRD | Director/Board Member | 59 | 21-07-31 |
Director/Board Member | 54 | 22-01-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 562,175 | 545,084 ( 96.96 %) | 0 | 96.96 % |
Company contact information
Dermata Therapeutics, Inc.
3525 Del Mar Heights Road Suite 322
92130, San Diego
+
http://www.dermatarx.com![address Dermata Therapeutics, Inc.(DRMA)](https://cdn.zonebourse.com/static/address/125841159.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.21% | 1.33M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- DRMA Stock
- Company Dermata Therapeutics, Inc.